1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Sean Sachdev: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial Biopsy, Biospecimen Collection, Computed Tomography - Prostate Adenocarcinoma | Phase 2 | Recruiting | Sean Sachdev | 50 | 2024-09-06 | 2026-10-30 |
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1) · Biopsy (1) · Magnetic Resonance Spectroscopy (1) · Radiotherapy, Image-Guided (1) · Specimen Handling (1) · enzalutamide (1) · relugolix (1)
United States (1)
P30CA060553 (1)